Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:38088rdf:typepubmed:Citationlld:pubmed
pubmed-article:38088lifeskim:mentionsumls-concept:C0026030lld:lifeskim
pubmed-article:38088lifeskim:mentionsumls-concept:C1882726lld:lifeskim
pubmed-article:38088lifeskim:mentionsumls-concept:C1522492lld:lifeskim
pubmed-article:38088lifeskim:mentionsumls-concept:C0066479lld:lifeskim
pubmed-article:38088pubmed:issue3lld:pubmed
pubmed-article:38088pubmed:dateCreated1979-10-24lld:pubmed
pubmed-article:38088pubmed:abstractTextIn the presence of phenobarbital-pretreated rat liver microsomes and under oxidative conditions, metyrapone is transformed in vitro into reduced metyrapone and two other metabolites. In an effort to further characterize those metabolites, large-scale incubations of metyrapone were performed. Untransformed substrate and metabolites were extracted into chloroform under alkaline conditions and separated by thin-layer chromatography. The nature of the metabolites as N-oxides located on either pyridine ring was established by physical methodologies, mainly electron-impact and chemical-ionization mass spectrometry, and also by chemical reactions with titanous chloride. The formation of both N-oxides was increased in microsomes from phenobarbital-, but not from 3-methylcholanthrene-pretreated animals. N-Oxide formation during metyrapone metabolism might be an important step in its inhibitory action on the cytochrome P-450-mediated drug metabolism.lld:pubmed
pubmed-article:38088pubmed:languageenglld:pubmed
pubmed-article:38088pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:38088pubmed:citationSubsetIMlld:pubmed
pubmed-article:38088pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:38088pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:38088pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:38088pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:38088pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:38088pubmed:statusMEDLINElld:pubmed
pubmed-article:38088pubmed:issn0090-9556lld:pubmed
pubmed-article:38088pubmed:authorpubmed-author:KahnTTlld:pubmed
pubmed-article:38088pubmed:authorpubmed-author:KahlG FGFlld:pubmed
pubmed-article:38088pubmed:authorpubmed-author:GielenJ EJElld:pubmed
pubmed-article:38088pubmed:authorpubmed-author:MaumiFFlld:pubmed
pubmed-article:38088pubmed:authorpubmed-author:TüttenbergK...lld:pubmed
pubmed-article:38088pubmed:authorpubmed-author:De GraeveJJlld:pubmed
pubmed-article:38088pubmed:issnTypePrintlld:pubmed
pubmed-article:38088pubmed:volume7lld:pubmed
pubmed-article:38088pubmed:ownerNLMlld:pubmed
pubmed-article:38088pubmed:authorsCompleteYlld:pubmed
pubmed-article:38088pubmed:pagination166-70lld:pubmed
pubmed-article:38088pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:38088pubmed:meshHeadingpubmed-meshheading:38088-An...lld:pubmed
pubmed-article:38088pubmed:meshHeadingpubmed-meshheading:38088-Ra...lld:pubmed
pubmed-article:38088pubmed:meshHeadingpubmed-meshheading:38088-Me...lld:pubmed
pubmed-article:38088pubmed:meshHeadingpubmed-meshheading:38088-Ma...lld:pubmed
pubmed-article:38088pubmed:meshHeadingpubmed-meshheading:38088-Cy...lld:pubmed
pubmed-article:38088pubmed:meshHeadingpubmed-meshheading:38088-Ph...lld:pubmed
pubmed-article:38088pubmed:meshHeadingpubmed-meshheading:38088-NA...lld:pubmed
pubmed-article:38088pubmed:meshHeadingpubmed-meshheading:38088-Me...lld:pubmed
pubmed-article:38088pubmed:meshHeadingpubmed-meshheading:38088-Mi...lld:pubmed
pubmed-article:38088pubmed:meshHeadingpubmed-meshheading:38088-Ma...lld:pubmed
pubmed-article:38088pubmed:articleTitleFormation of two metyrapone N-oxides by rat liver microsomes.lld:pubmed
pubmed-article:38088pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:38088lld:pubmed